Talis Biomedical Corporation Net Income 2011-2026 | TLIS

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.^[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Talis Biomedical Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-62 M	-113 M	-192 M	-	-27.5 M	-21.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-21.3 M	-192 M	-83.2 M

Quarterly Net Income Talis Biomedical Corporation

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-8.85 M	-13 M	-	-15.7 M	-15 M	-17.8 M	-	-26 M	-27 M	-33.1 M	-	-38.4 M	-64.5 M	-60.5 M	-	-29.5 M	-10 M	-7.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-7.37 M	-64.5 M	-26.2 M

References

Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer	Net Income	Price	% 24h	Market Cap	Country
AdaptHealth Corp. AHCO	-70.8 M	$ 13.14	0.19 %	$ 1.78 B	USA
BIOLASE BIOL	-20.6 M	-	-13.19 %	$ 166 K	USA
GenMark Diagnostics, Inc. GNMK	-18.6 M	-	-	$ 1.77 B	USA
Allied Healthcare Products AHPI	-1.94 M	-	3.58 %	$ 2.21 M	USA
Eargo EAR	-157 M	-	-	$ 10.2 M	USA
Delcath Systems DCTH	2.7 M	$ 10.67	2.79 %	$ 382 M	USA
Apollo Endosurgery APEN	-39.8 M	-	-	$ 475 M	USA
Obalon Therapeutics, Inc. OBLN	-12.3 M	-	-5.86 %	$ 30.6 M	USA
Second Sight Medical Products EYES	-26.6 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	7.54 M	$ 25.93	0.86 %	$ 219 M	USA
Avinger AVGR	-18.3 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-59.7 M	-	-	$ 3.31 B	USA
Helius Medical Technologies HSDT	-8.85 M	$ 2.12	3.92 %	$ 1.29 M	USA
Aziyo Biologics AZYO	53.4 M	-	1.37 %	$ 20.5 M	USA
EDAP TMS S.A. EDAP	-19 M	$ 3.48	4.77 %	$ 130 M	France
Inspire Medical Systems INSP	145 M	$ 56.12	-0.04 %	$ 1.65 B	USA
BioSig Technologies BSGM	-463 M	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	-50.5 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	-25.5 M	$ 11.24	0.54 %	$ 318 M	USA
LivaNova PLC LIVN	-242 M	$ 60.35	0.41 %	$ 3.29 B	Britain
Cardiovascular Systems CSII	-36.9 M	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	-8.2 M	$ 0.63	2.87 %	$ 39.2 M	USA
CryoLife, Inc. CRY	-16.7 M	-	-4.14 %	$ 702 M	USA
Invacare Corporation IVC	-20.6 M	-	-	$ 24.7 M	USA
Soliton, Inc. SOLY	-14.5 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-9.14 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-10.9 M	-	0.03 %	$ 1.58 B	Israel
IRIDEX Corporation IRIX	-4.44 M	$ 1.05	1.46 %	$ 17.8 M	USA
Dynatronics Corporation DYNT	-10.9 M	-	14.99 %	$ 929 K	USA
Misonix, Inc. MSON	-17.4 M	-	-	$ 462 M	USA
Neovasc NVCN	-24.9 M	-	-	$ 111 M	Canada
OrthoPediatrics Corp. KIDS	-39.6 M	$ 14.91	-1.0 %	$ 350 M	USA
Sintx Technologies SINT	-10.4 M	$ 2.27	9.13 %	$ 6.3 M	USA
Butterfly Network BFLY	-72.5 M	$ 5.03	5.01 %	$ 1.06 B	USA
Intersect ENT, Inc. XENT	-72.3 M	-	-	$ 955 M	USA
Stryker Corporation SYK	849 M	$ 301.1	-4.45 %	$ 115 B	USA
GBS GBS	-10.6 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	538 M	$ 91.13	1.05 %	$ 12.3 B	USA
TransMedics Group TMDX	190 M	$ 99.9	-0.88 %	$ 3.4 B	USA
Tandem Diabetes Care TNDM	-589 K	$ 19.84	1.61 %	$ 1.35 B	USA
NanoVibronix NAOV	-18.2 M	-	-	$ 1.08 M	USA
CONMED Corporation CNMD	47.1 M	$ 36.75	0.25 %	$ 1.14 B	USA
Integer Holdings Corporation ITGR	103 M	$ 85.65	-3.23 %	$ 2.98 B	USA
Edwards Lifesciences Corporation EW	1.07 B	$ 83.98	0.57 %	$ 49.1 B	USA
LENSAR LNSR	-34.3 M	$ 5.45	4.11 %	$ 65.2 M	USA
Pulmonx Corporation LUNG	-54 M	$ 1.37	6.64 %	$ 55.7 M	USA
MiMedx Group MDXG	48.6 M	$ 3.61	6.85 %	$ 534 M	USA
Myomo MYO	-15.6 M	$ 0.89	3.01 %	$ 37.3 M	USA